A detailed history of Ubs Asset Management Americas Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,994,500 shares of IOVA stock, worth $22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,994,500
Previous 179,850 1008.98%
Holding current value
$22 Million
Previous $2.67 Million 500.19%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.78 - $14.19 $14.1 Million - $25.7 Million
1,814,650 Added 1008.98%
1,994,500 $16 Million
Q1 2024

May 15, 2024

SELL
$7.59 - $17.47 $356 - $821
-47 Reduced 0.03%
179,850 $2.67 Million
Q4 2023

Feb 14, 2024

SELL
$3.3 - $8.89 $5,824 - $15,690
-1,765 Reduced 0.97%
179,897 $1.46 Million
Q3 2023

Nov 13, 2023

BUY
$4.44 - $8.79 $237,500 - $470,185
53,491 Added 41.73%
181,662 $826,000
Q3 2022

Nov 14, 2022

SELL
$9.53 - $13.11 $272,901 - $375,417
-28,636 Reduced 18.26%
128,171 $1.23 Million
Q2 2022

Aug 12, 2022

SELL
$6.38 - $18.33 $387,444 - $1.11 Million
-60,728 Reduced 27.92%
156,807 $1.73 Million
Q1 2022

May 16, 2022

BUY
$12.38 - $19.1 $488,688 - $753,953
39,474 Added 22.17%
217,535 $3.62 Million
Q4 2021

Feb 14, 2022

BUY
$16.55 - $27.63 $63,452 - $105,933
3,834 Added 2.2%
178,061 $3.4 Million
Q3 2021

Nov 15, 2021

SELL
$20.35 - $26.63 $34,269 - $44,844
-1,684 Reduced 0.96%
174,227 $4.3 Million
Q2 2021

Aug 16, 2021

SELL
$16.33 - $33.07 $2.19 Million - $4.43 Million
-134,088 Reduced 43.25%
175,911 $4.58 Million
Q1 2021

May 14, 2021

SELL
$28.67 - $52.59 $16,886 - $30,975
-589 Reduced 0.19%
309,999 $9.81 Million
Q4 2020

Mar 01, 2021

BUY
$28.04 - $50.26 $575,689 - $1.03 Million
20,531 Added 7.08%
310,588 $14.4 Million
Q3 2020

Nov 13, 2020

SELL
$27.75 - $36.3 $416 - $544
-15 Reduced 0.01%
290,057 $9.55 Million
Q2 2020

Aug 14, 2020

BUY
$27.21 - $41.0 $732,411 - $1.1 Million
26,917 Added 10.23%
290,072 $7.96 Million
Q1 2020

May 15, 2020

BUY
$19.54 - $38.85 $3.01 Million - $5.99 Million
154,293 Added 141.73%
263,155 $7.88 Million
Q4 2019

Feb 14, 2020

BUY
$17.95 - $29.41 $489,191 - $801,510
27,253 Added 33.39%
108,862 $3.01 Million
Q3 2019

Nov 14, 2019

BUY
$17.99 - $26.0 $346,379 - $500,604
19,254 Added 30.88%
81,609 $1.49 Million
Q2 2019

Aug 15, 2019

BUY
$9.78 - $24.52 $150,318 - $376,872
15,370 Added 32.71%
62,355 $0
Q4 2018

Feb 13, 2019

BUY
$7.51 - $11.93 $80,184 - $127,376
10,677 Added 29.41%
46,985 $415,000
Q1 2018

May 14, 2018

BUY
$8.1 - $19.5 $210,980 - $507,916
26,047 Added 253.84%
36,308 $0
Q3 2017

Nov 13, 2017

BUY
$4.45 - $8.55 $45,661 - $87,731
10,261
10,261 $0

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.